Cellestia Biotech AG
Cellestia is developing a new drug against a specific form of cancer, for which no therapy is available. They discovered a molecule with a novel mode of action, that is able to control the so-called ‘Notch Signaling Pathway’, which is a means for cells to communicate with each other and, if this communication is out of control, can lead to development of cancer. It is also a mechanism for cancer turning resistant to treatment.
Subscribe to Our Newsletter
Receive our monthly newsletter by email